AssayQuant Technologies Inc

Founded by scientists in 2015, AssayQuant Technologies provides robust, easy-to-use assays backed by innovative and proven technologies to enable drug discovery research.

Over 400 unique continuous enzyme and inhibitor activity assays are available, all based on their patented PhosphoSens® Technology. Available as kits or bulk sensor-peptides, these assays use novel sensor-peptide substrates and feature components that are carfully tested for optimal performance in their application.

AssayQuant assays accerlerate drug development abd efficacy, with potency results from their assays aligning with those from cell-based assays, supporting faster and more effective lead identification, characterisation, profiling and optimisation.